Maria Cristina Cox

15PUBLICATIONS
65CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursEpidemiological methodsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 18, 2026
Co-occurrence of angioimmunoblastic T-cell lymphoma and aggressive-refractory plasma-cell neoplasm: Two new cases and literature review.

M Christina Cox, Claudia Seimonte, Erica Giacobbi

|Jan 28, 2026
Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective Analysis.

Sabrina Pelliccia, Marta Banchi, Lucrezia De Marchi

|Dec 24, 2025
Health-Related Quality of Life and Symptom Burden in Patients with Diffuse Large B-Cell Lymphoma Before Treatment with Tafasitamab and Lenalidomide: An Ad Hoc Analysis of Italian Real-World Data from the PRO-MIND Study.

Pier Luigi Zinzani, Nicola Battaglia, Mario Lapecorella

|Mar 13, 2025
The Impact of Radiotherapy and Attenuated Chemotherapy Regimens in Older Patients with Classic Hodgkin Lymphoma: A Real-Life Study from the ReLLi Network.

Maria Christina Cox, Matteo Caridi, Alexandro Patirelis

|Mar 08, 2025
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study.

Alessandra Tucci, Alessandro Re, Chiara Pagani

|Nov 25, 2023
Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11, 7162.

Guido Bocci, Sabrina Pelliccia, Paola Orlandi

Pageof 3

Frequent Collaborators

3 joint publications

Guido Bocci

2 joint publications

Annalisa Arcari

2 joint publications

Stefan Hohaus

2 joint publications

Gerardo Musuraca